![Amnon Peled](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amnon Peled
Chief Executive Officer at Biokine Therapeutics Ltd.
Amnon Peled active positions
Companies | Position | Start | End |
---|---|---|---|
Biokine Therapeutics Ltd.
![]() Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | Director/Board Member | 1999-12-31 | - |
Chief Executive Officer | 1999-12-31 | - | |
Chief Tech/Sci/R&D Officer | 1999-12-31 | - | |
Founder | 1999-12-31 | - | |
Sakura Bio
![]() Sakura Bio BiotechnologyHealth Technology Sakura Bio is a start-up company based in Jerusalem, Israel. Sakura Bio is developing an off-the-shelf, allogeneic T-cell therapy to fight cancer. The Israeli company's lead product, SAK-T (Super Activated Killer T-cell), is a unique T-cell population with superior anti-tumor cytotoxic activity and no toxicity of healthy tissue. The company was founded by Dikla Berko-Ashur and Amnon Peled, with Dikla Berko-Ashur serving as CEO since incorporation. | Chief Tech/Sci/R&D Officer | - | - |
Founder | - | - |
Career history of Amnon Peled
Training of Amnon Peled
Weizmann Institute of Science | Doctorate Degree |
Statistics
International
Israel | 4 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Director/Board Member | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Biokine Therapeutics Ltd.
![]() Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | Health Technology |
Sakura Bio
![]() Sakura Bio BiotechnologyHealth Technology Sakura Bio is a start-up company based in Jerusalem, Israel. Sakura Bio is developing an off-the-shelf, allogeneic T-cell therapy to fight cancer. The Israeli company's lead product, SAK-T (Super Activated Killer T-cell), is a unique T-cell population with superior anti-tumor cytotoxic activity and no toxicity of healthy tissue. The company was founded by Dikla Berko-Ashur and Amnon Peled, with Dikla Berko-Ashur serving as CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Amnon Peled
- Experience